{"id":"NCT03439137","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan","officialTitle":"A Phase III, Double Blind, Confirmatory Study of MT-6548 Compared to Darbepoetin Alfa in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-02-14","primaryCompletion":"2018-12-12","completion":"2019-07-16","firstPosted":"2018-02-20","resultsPosted":"2021-04-12","lastUpdate":"2023-12-28"},"enrollment":323,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Anemia; Hemodialysis Dependent Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"MT-6548","otherNames":["vadadustat","AKB-6548"]},{"type":"DRUG","name":"Darbepoetin alfa","otherNames":[]},{"type":"DRUG","name":"MT-6548-matching placebo","otherNames":[]},{"type":"DRUG","name":"Darbepoetin alfa-matching placebo","otherNames":[]}],"arms":[{"label":"MT-6548","type":"EXPERIMENTAL"},{"label":"Darbepoetin alfa","type":"ACTIVE_COMPARATOR"}],"summary":"For hemodialysis subjects currently receiving ESAs with anemia associated with chronic kidney disease, demonstrate non-inferiority of MT-6548 compared to darbepoetin alfa using Hb value and evaluate long-term safety of MT-6548.","primaryOutcome":{"measure":"Mean Hb Level of Week 20 and Week 24","timeFrame":"Up to Week 24","effectByArm":[{"arm":"MT-6548","deltaMin":10.61,"sd":null},{"arm":"Darbepoetin Alfa","deltaMin":10.65,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":15},"locations":{"siteCount":28,"countries":["Japan"]},"refs":{"pmids":["33650630","38530490","36005278"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":162},"commonTop":["Nasopharyngitis","Diarrhoea","Shunt stenosis","Contusion","Vomiting"]}}